CODEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Codeine, and when can generic versions of Codeine launch?
Codeine is a drug marketed by Hikma, Lannett Co Inc, and Scherer Labs. and is included in six NDAs.
The generic ingredient in CODEINE is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CODEINE?
- What are the global sales for CODEINE?
- What is Average Wholesale Price for CODEINE?
Summary for CODEINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for CODEINE |
| DailyMed Link: | CODEINE at DailyMed |
US Patents and Regulatory Information for CODEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CODEINE SULFATE | codeine sulfate | SOLUTION;ORAL | 202245-001 | Jun 30, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lannett Co Inc | CODEINE SULFATE | codeine sulfate | TABLET;ORAL | 203046-003 | Jun 13, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | CODEINE SULFATE | codeine sulfate | TABLET;ORAL | 022402-003 | Jul 16, 2009 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
